Mark Kozloff to Neoplasms
This is a "connection" page, showing publications Mark Kozloff has written about Neoplasms.
Connection Strength
0.115
-
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors. Invest New Drugs. 2014 Aug; 32(4):700-9.
Score: 0.041
-
Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours. Br J Cancer. 2012 Oct 09; 107(8):1268-76.
Score: 0.036
-
Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumours. Br J Cancer. 2012 Oct 09; 107(8):1277-85.
Score: 0.036
-
Acute nephrotoxicity following cis-dichlorodiammine-platinum. Cancer. 1982 May 01; 49(9):1784-8.
Score: 0.001